A cross-sectional survey of health state impairment and treatment patterns in patients with postherpetic neuralgia

Age and Ageing

Volumn 35, Issue 2, 2006, Pages 132-137

  van Seventer, Robert ^a   Sadosky, Alesia ^b   Lucero, Melanie ^b   Dukes, Ellen ^b  

^a AMPHIA HOSPITAL   (Netherlands)

^b PFIZER INC   (United States)

Author keywords

Elderly; Health status; Herpes zoster; Neuropathic pain; Patient burden; Postherpetic neuralgia; Quality of life

Indexed keywords

ACETYLSALICYLIC ACID; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ANTIINFLAMMATORY AGENT; BENZODIAZEPINE DERIVATIVE; BUSPIRONE; CARBAMAZEPINE; GABAPENTIN; HYPNOTIC AGENT; HYPNOTIC SEDATIVE AGENT; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PROSTAGLANDIN SYNTHASE INHIBITOR; TOPICAL AGENT; TRAMADOL; VITAMIN;

ADULT; AGED; ANXIETY DISORDER; ARTICLE; CLINICAL PROTOCOL; COMORBIDITY; DAILY LIFE ACTIVITY; DEPRESSION; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; ELDERLY CARE; EUROPE; EXERCISE; FEMALE; GENERAL PRACTICE; GERIATRIC PATIENT; HEALTH CARE UTILIZATION; HEALTH STATUS; HERB; HERPES ZOSTER; HUMAN; HUMAN RELATION; MAJOR CLINICAL STUDY; MALE; MOOD; OBSERVATIONAL METHOD; PAIN ASSESSMENT; PHYSIOTHERAPY; POSTHERPETIC NEURALGIA; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; QUALITY OF LIFE INDEX; QUESTIONNAIRE; SLEEP; SLEEP DISORDER; TREATMENT DURATION; TREATMENT OUTCOME; WALKING;

AGED; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH STATUS; HERPES ZOSTER; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEURALGIA, POSTHERPETIC; PAIN MEASUREMENT; QUALITY OF LIFE; QUESTIONNAIRES;

HERPES ZOSTER;

EID: 33644985635     PISSN: 00020729     EISSN: 14682834     Source Type: Journal    
DOI: 10.1093/ageing/afj048     Document Type: Article

References (30)

1. Schmader KE. Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy. Clin J Pain 2002; 18: 350-4.
2. Lydick E, Epstein RS, Himmelberger D, White CJ. Area under the curve: A metric for patient subjective responses in episodic diseases. Qual Life Res 1995; 4: 41-5.
3. Katz J, Cooper EM, Walther RR, Sweeney EW, Dworkin RH. Acute pain in herpes zoster and its impact on health-related quality of life. Clin Infect Dis 2004; 39: 342-8.
4. Dworkin RH, Portenoy RK. Pain and its persistence in herpes zoster. Pain 1996; 67: 241-51.
5. Dworkin RH, Schmader KE. The epidemiology and natural history of herpes zoster and postherpetic neuralgia. In: Watson CPN, ed. Herpes Zoster and Postherpetic Neuralgia. Amsterdam: Elsevier, 2001, 39-65.
6. Choo PW, Galil K, Donahue JG, Walker AM, Spiegelman D, Platt R. Risk factors for postherpetic neuralgia. Arch Intern Med 1997; 157: 1217-24.
7. Jung BF, Johnson RW, Griffin DR, Dworkin RH. Risk factors for postherpetic neuralgia in patients with herpes zoster. Neurology 2004; 62: 1545-55.
8. Kost RG, Straus SE. Postherpetic neuralgia - pathogenesis, treatment, and prevention. N Engl J Med 1996; 335: 32-42.
9. Dworkin RH, Backonja M, Rowbotham MC et al. Advances in neuropathy pain: Diagnosis, mechanisms, and treatment recommendations. Arch Neurol 2003; 60: 1524-34.
10. Backonja M, Glanzman R. Gabapentin dosing for neuropathy pain: Evidence from randomized, placebo-controlled clinical trials. Clin Ther 2003; 25: 81-104.
11. Haythornthwaite JA, Benrud-Larson LM. Psychological aspects of neuropathic pain. Clin J Pain 2000; 16 (2 Suppl.): S101-5.
12. Meyer-Rosberg K, Kvarnstrom A, Kinnman E, Gordh T, Nordfors L, Kristofferson A. Peripheral neuropathic pain - a multidimensional burden for patients. Eur J Pain 2001; 5: 379-89.
13. Oster G, Harding G, Dukes E, Edelsberg J, Cleary PD. Pain, medication use, and health-related quality of life in older persons with post-herpetic neuralgia. Results from a population-based survey. J Pain 2005; 6: 356-63.
14. Rowbotham MC, Harden N, Stacey B, Bernstein P, Magnus-Miller L, for the Gabapentin Postherpetic Neuralgia Study Group. Gabapentin for the treatment of postherpetic neuralgia. A randomized controlled trial. JAMA 1998; 280: 1837-42.
15. Katz NP, Gammaitoni AR, Davis MW, Dworkin RH, Lidoderm Patch Study Group. Lidocaine patch 5% reduces pain intensity and interference with quality of life in patients with postherpetic neuralgia: An effectiveness trial. Pain Med 2002; 3: 324-32.
16. Dworkin RH, Corbin AE, Young JP Jr et al. Pregabalin for the treatment of postherpetic neuralgia. A randomized, placebo-controlled trial. Neurology 2003; 60: 1274-83.
17. Markman JD, Dukes E, Siffert J, Griesing T. Patient flow in neuropathic pain management understanding existing patterns of care. [abstract] Eur J Neurol 2004; 11 (Suppl. 2): 135-6.
18. Coplan PM, Schmader KE, Nikas A et al. Development of a measure of the burden of pain due to herpes zoster and post-herpetic neuralgia for prevention trials: Adaptation of the Brief Pain Inventory. J Pain 2004; 5: 344-56.
19. McDermott AM, Toelle TR, Rowbotham DJ, Schaefer CP, Dukes EM. The burden of neuropathic pain: Results from a cross-sectional survey. Eur J Pain 2005; 10: 127-35. Published online 30 March 2005,
20. Zelman DC, Gore M, Dukes E, Tai K-S, Brandenburg N. Validation of a modified version of the Brief Pain Inventory for painful diabetic peripheral neuropathy. J Pain Symptom Manage 2005; 29: 401-10.
21. Daut RL, Cleeland CS, Flanery RC. Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases. Pain 1983; 17: 197-210.
22. Cleeland CS, Ryan KM. Pain assessment: Global use of the Brief Pain Inventory. Ann Acad Med Singapore 1994; 23: 129-38.
23. Brooks R. EuroQol: The current state of play. Health Policy 1996; 37: 53-72.
24. Zelman D, Dukes E, Brandenburg N, Bostrom A, Gore M. Identification of cut-points for mild, moderate and severe pain due to diabetic peripheral neuropathy. Pain 2005; 115: 29-36.
25. Dolan P. Modeling valuations for EuroQol health states. Med Care 1997; 35: 1095-108.
26. Tölle T, Xu X, Sadosky AB. Painful diabetic neuropathy: A cross-sectional survey of health state impairment and treatment patterns. J Diabetes complications 2006; 20: 26-33.
27. Dworkin RH. An overview of neuropathy pain; syndromes, symptoms, signs, and several mechanisms. Clin J Pain 2002; 18: 343-9.
28. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults. Results of a US consensus panel of experts. Arch Intern Med 2003; 163: 2716-24.
29. Oster G, Berger A, Dukes E, Edelsberg J, McCarberg B. Use of potentially inappropriate pain-related medications in older adults with painful neuropathic disorders. Am J Geriatr Pharmacother 2004; 2: 163-70.
30. Gilron I, Bailey J, Weaver DF, Houlden RL. Patients' attitudes and prior treatments in neuropathy pain: A pilot study. Pain Res Manag 2002; 7: 199-203.